Nemaura Medical, Inc. Common Stock
NMRD
NMRD was delisted on the 4th of January, 2024.
2 hedge funds and large institutions have $97K invested in Nemaura Medical, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 3 closing their positions.
50% less funds holding
Funds holding: 4 → 2 (-2)
56% less capital invested
Capital invested by funds: $222K → $97K (-$125K)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$45.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$95K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$56K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$14K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SC
1
Scotia Capital
Toronto,
Ontario, Canada
| $57K | – | – | – |
|
|
2
Citadel Advisors
Miami,
Florida
| $40K | +$45.9K | +1,418 | New |
|
|
3
Bank of America
Charlotte,
North Carolina
| – | -$95K | -2,083 | Closed |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$56K | -1,240 | Closed |
|
|
5
UBS Group
Zurich,
Switzerland
| – | -$14K | -311 | Closed |
|
NMRD Hedge Fund Activity: Q2 2018 in Review
2 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Nemaura Medical, Inc. Common Stock (NMRD) for Q2 2018, worth a combined $97K — down 56% from $222K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of NMRD and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $45.9K. The largest seller was Bank of America, exiting entirely with an estimated $95K sold.
- 2 institutional investors held Nemaura Medical, Inc. Common Stock (NMRD) as of Q2 2018, down from 4 in Q1 2018.
- Funds reported $97K of Nemaura Medical, Inc. Common Stock stock for Q2 2018, down 56% quarter-over-quarter.
- 1 fund opened new Nemaura Medical, Inc. Common Stock positions in Q2 2018 and 3 closed out, a net change of -2 holders.
- The largest Nemaura Medical, Inc. Common Stock buyer in Q2 2018 was Citadel Advisors, an estimated $45.9K added.
- The largest Nemaura Medical, Inc. Common Stock seller in Q2 2018 was Bank of America, an estimated $95K sold.
Based on aggregated 13F filings for Q2 2018.